Clinical trials
Carcinoma, Merkel Cell trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Terminated | 2 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Incyte Corporation | 2 |
| 4SC AG | 1 |
| AbbVie | 1 |
| ImaginAb, Inc. | 1 |
| Incyte Biosciences International Sàrl | 1 |
| Jules Bordet Institute | 1 |
| Transgene | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Merkel Cell | 8 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Small Cell Lung Carcinoma | 5 |
| Carcinoma, Hepatocellular | 4 |
| Carcinoma, Renal Cell | 4 |
| Melanoma | 4 |
| Mesothelioma | 4 |
| Carcinoma, Transitional Cell | 3 |
| Neoplasm Metastasis | 3 |
| Triple Negative Breast Neoplasms | 3 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.